Immunolocalization of human gelatinase (type iv collagenase, mmp-9) and tissue inhibitor of metalloproteinase 1 in hailey-hailey and darier’s diseases)

Dermatology

Volumn 193, Issue 2, 1996, Pages 110-114

  Kobayashi, T ^a   Sakuraoka, K ^a   Hattori, S ^b   Hori, H ^b   Nagai, Y ^b   Tajima, S ^a   Nishikawa, T ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Darier rsquo; s disease; Gelatinase; Hailey Hailey disease; MMP 9; TIMP 1; Type IV collagenase

Indexed keywords

COLLAGENASE; GELATINASE; MONOCLONAL ANTIBODY; TISSUE INHIBITOR OF METALLOPROTEINASE;

ACANTHOLYSIS; ARTICLE; CELL CULTURE; DARIER DISEASE; DYSKERATOSIS; FETUS; HAILEY HAILEY DISEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PRIORITY JOURNAL; TISSUE METABOLISM;

EID: 0029847322     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246223     Document Type: Article

References (34)

1. Wolff K: The enigma of Kaposi's sarcoma: an answer at last? Clin Exp Dermatol 1992:17: 145-151.
2. Penn I: Kaposi's sarcoma in immunosup-pressed patients. J Clin Lab Immunol 1983:12: I-10.
3. Harwood AR. Osoba D. Hofstader SL. Goldstein MB. Cardella CJ. Holecek MJ. Kunynctz R. Giammarco RA: Kaposi's sarcoma in recipients of renal transplants. Am J Med 1979:67: 759-765.
4. Euvrard S: Cutaneous complications in renal transplant recipients. Bur J Dermatol 1991:1: 175-185.
5. Frances C. Farge D. Boisnic S: Syndrome de Kaposi des transplantés. J Mal Vase 1991:16: 163-165.
6. Bismuth H. Samuel D. Venencie PY. Menouar G. Szekely AM: Development of Kaposi's sarcoma in liver transplant recipients: Characteristics. management and outcome. Transplant Proc 1991;23:1438-1439.
7. Farge D: Kaposi's sarcoma in organ transplant recipients. Eur J Med 1993;2:339-343.
8. Kadry Z. Bronsther O. Van Thiel D H. Ran-dhawa P. Fung JJ. Starzl TE: Kaposi's sarcoma in two primary liver allograft recipients occurring under FK506 immunosuppression. Clin T ransplant 1993:7:188-194.
9. Dupin N. Grandadam M, Calvez V. Gorin I. Aubin JT. Havard S. Lamy F. Leibowitch M. Hurauy JM. Escande JP. Agut H: Herpesvirus-like DNA sequences in patients with Mediterranean Kaposi's sarcoma. Lancet 1995:345: 761-762.
10. Al-Khader A. Suleiman M. Al-Hasani M. Halccm A: Posttransplant Kaposi sarcoma: Staging as a guide to therapy and prognosis. Nephron 1988:48:165.
11. Touraine JL. Raffaele P. Traeger J. Gamier JL. Lefrançois N. Pouteil-Noblc C. Marrast AC. Daoud S. Euvrard S: Kaposi's Sarcoma in Organ Transplantation (Lyon Experience. 1965-1995). Transplant Clin Immunol. Dordrecht, Kluwer 1996:27:73-80.
12. Qunibi W. Akhtar M. Sheth K. Earl Ginn H. Al-Furayh O. Devol EB. Taller S: Kaposi's sarcoma: The most common tumor after renal transplantation in Saudi Arabia. Am J Med 1988:84:225-232.
13. Brunson ME. Balakrishnan K. Penn I: IILA and Kaposi's sarcoma in solid organ transplantation. Hum Immunol 1990:29:56-63.
14. Penn I. Brunson ME: Cancers after cyclosporine therapy. Transplant Proc 1988:20: 885-892.
15. Swinnen LJ. Costanzo-Nordin MR. Fisher SG. O'Sullivan EJ. Johnson MR, Heroux AL. Dizikes GJ. Pilaire R. Fisher Rl: Increased incidence of lymphoproliférative disorder alter immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Engl J Med 1990:323:1723-1727.
16. Penn I: Tumors of the immunocompromised host. Annu Rev Med 1988:39:63-73.
17. Kanitakis J. Moayed J. Hoyo E, Schmitt D: Expression of the human progenitor cell antigen (CD34) in skin tumours. Eur J Dermatol 1994; 4:53-57.
18. Al-Sulaiman MH. Mousa DH. Dhar JM. Al-Kadher AA: Does regressed posttransplantation Kaposi's sarcoma recur following réintroduction of immunosuppression? Am J Nephrol 1992:12:384-386.
19. Sokal EM. Garagiozoglou T. Lamy M. Reding R. Otic JB: Epstein-Barr virus serology and Epslein-Barr virus associated lymphoproliférative disorders in pediatric liver transplant recipients. Transplantation 1993:56:1394-1398.
20. Siegal B.Levinton-KrissS. Schiffer A, Sayar J. Engelberg I. Vonsover A. Ramon Y, Rubinstein E: Kaposi's sarcoma in immunosuppression: Possibly the result of a dual viral infection. Cancer 1990;65:492-498.
21. Grody WW. Lewin KJ. Naieim F: Detection of cytomegalovirus DNA in classic and epidemic Kaposi's sarcoma by in situ hybridization. Hum Pathol 1988; 19:524-528.
22. Sciniciarello F. Rady P. Cloyd MW.Tyring SK: HPV-18 in HIV-associated Kaposi's sarcoma. Lancet 1991:337:501.
23. Huang YQ. Li JJ. Rush MG. Poiesz BJ. Nico-laides A. Jacobson M. Zhang WG. Couvatas E. Ahott MA, Friedman-Kien AE: HPV-16 related DNA sequences in Kaposi's sarcoma. Lancet 1992:339:515-518.
24. Moore P. Chang Y: Detection of Herpesviruslike DNA sequences in Kaposi's sarcoma skin in pat ents with and those without HIV infection. N Engl J Med 1995;332:1181-1185.
25. Lebbé C. De Cremoux P. Rybojad M. Costa da Cunha C. Morel P. Calvo F: Kaposi's sarcoma and new herpes virus. Lancet 1995:345:1180.
26. Boshoff C. Whitby D. Hatziioannou T. Fisher C. Van der Walt J. ! latzakis A. Weiss R. Schulz T: Kaposi's-sarcoma-associated herpesvirus in HIV-negative Kaposi's sarcoma. Lancet 1995: 345:1043.
27. Rady PL, Yen A. Rollefson JL, Orcngo I. Bruce S. Hughes TK. Tyring SK: Herpesvirus-like DNA sequences in non-Kaposi's sarcoma skin lesions of transplant patients. Lancet 1995:345: 1339-1340.
28. Penn I: Tumors after renal and cardiac transplantation. Hematol Oncol Clin North Am 1993;7:431-435.
29. Ramos HC. Reyes J, Abu-Elmagd K. Zeevi A, Reinsmoen N. Tzakis A. Demetris A, Fung JJ. Flynn B. McMiehael J. Ebert F. Starzl TE: Weaning of immunosuppression in long-term liver transplant recipients. Transplantation 1995;59:212-217.
30. Tur E. Brenner S. Michalevicz R: Low dose recombinant interferon alpha treatment for classic Kaposi's sarcoma. Arch Dermatol 1993: 129:1297-1300.
31. Dousset B. Conti F. Houssin D, Calmus Y: Acute vanishing bile duct syndrome after interferon therapy for recurrent HCV infection in liver transplant recipients. N Engl J Med 1994: 330:1160-1161.
32. Villanil FG. Petrovic L. Hu KQ. Vierling JM: Efficacy and safety of alpha-2b-interferon therapy for hepatitis C after liver transplantation. Hepatology 1994:19:1381.
33. Wright HI. Gavaler JS. Van Thiel DH: Preliminary experience with alpha-2b-interferon therapy of viral hepatitis in liver allograft recipients. Transplantation 1992:53:121-124.
34. Magnone M. Holley J. Shapiro R. Scanllebury V. McCauley J. Jordan M. Vivas C. Starzl T, Johnson J: lnterferon-oc induced acute renal allograft rejection. Transplantation 1994:59: 1068-1070.